González-Ruiz Francisco J, Lazcano-Díaz Emmanuel A, Baeza Herrera Luis A, Villalobos-Pedroza Montserrat, Toledo Alemán Enma L, Zuñiga-Salcedo Miriam G, Cruz-Rodríguez Camelia, López-Polanco Alexandra, Torres-Pulido Abraham, Sierra-González de Cossio Alejandro, Cota Apodaca Luis A, Manzur-Sandoval Daniel
Department of Cardiovascular Critical Care, National Institute of Cardiology "Dr. Ignacio Chávez,", Mexico City, México.
Department of Cardiovascular Diseases, National Institute of Cardiology "Dr. Ignacio Chávez,", Mexico City, Mexico.
Ann Med Surg (Lond). 2022 Jun;78:103820. doi: 10.1016/j.amsu.2022.103820. Epub 2022 May 17.
The severe acute respiratory syndrome coronavirus 2 pandemic has continued to impact global health. However, while immunity acquired by vaccines has been developed, 40% of the world's population has still not been vaccinated. Economic problems associated with acquiring novel therapies, misinformation, and differences in treatment protocols have generated catastrophic results, especially in low-resource countries. Understanding the pathophysiological aspects of coronavirus disease and the therapeutic strategies that have been validated to date is essential for successful medical care. In this review, I summarize the historical aspects of the virus, molecules involved in infecting the host, and consequences of viral interactions with and in tissues.
严重急性呼吸综合征冠状病毒2大流行持续影响全球健康。然而,尽管已研发出通过疫苗获得的免疫力,但全球仍有40%的人口尚未接种疫苗。获取新型疗法相关的经济问题、错误信息以及治疗方案的差异已产生灾难性后果,尤其是在资源匮乏的国家。了解冠状病毒病的病理生理学方面以及迄今已得到验证的治疗策略对于成功的医疗护理至关重要。在本综述中,我总结了该病毒的历史背景、感染宿主所涉及的分子以及病毒与组织相互作用及其在组织中的后果。